Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bock

Showing results (131-140 of 202) with videos related to

Pageof 21
Sort By:
Plant Communications|April 13, 2023
Genomics of plant speciationDan G Bock, Zhe Cai, Cassandra Elphinstone, et al.
Genes|August 24, 2018
Neo-Domestication of an Interspecific Tetraploid <i>Helianthus annuus</i> × <i>Helianthus tuberous</i> Population That Segregates for Perennial HabitMichael B Kantar, Sariel Hüber, Adam Herman, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2005
Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine seriesScott D Kuduk, Ronald K Chang, Christina Ng, et al.
Biochemistry|November 30, 2006
Identification of the critical residues of bradykinin receptor B1 for interaction with the kinins guided by site-directed mutagenesis and molecular modelingSookhee N Ha, Pat J Hey, Rick W Ransom, et al.
Journal of Medicinal Chemistry|December 1, 1985
A uniquely potent renin inhibitor and its unanticipated plasma binding componentB E Evans, K E Rittle, M G Bock, et al.
Journal of Medicinal Chemistry|October 24, 2023
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory DisordersDavid Harrison, Andy Billinton, Mark G Bock, et al.
Journal of Medicinal Chemistry|October 1, 1987
Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy terminiM G Bock, R M DiPardo, B E Evans, et al.
Journal of Medicinal Chemistry|March 4, 1994
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm laborP D Williams, P S Anderson, R G Ball, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Progress in the development of oxytocin antagonists for use in preterm laborD J Pettibone, M Guidotti, C M Harrell, et al.
Journal of Medicinal Chemistry|October 1, 1988
Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potencyM G Bock, R M DiPardo, B E Evans, et al.
Pageof 21

Showing results (131-140 of 202) with videos related to

Sort By:
Pageof 21
Plant Communications|April 13, 2023
Genomics of plant speciationDan G Bock, Zhe Cai, Cassandra Elphinstone, et al.
Genes|August 24, 2018
Neo-Domestication of an Interspecific Tetraploid <i>Helianthus annuus</i> × <i>Helianthus tuberous</i> Population That Segregates for Perennial HabitMichael B Kantar, Sariel Hüber, Adam Herman, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2005
Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine seriesScott D Kuduk, Ronald K Chang, Christina Ng, et al.
Biochemistry|November 30, 2006
Identification of the critical residues of bradykinin receptor B1 for interaction with the kinins guided by site-directed mutagenesis and molecular modelingSookhee N Ha, Pat J Hey, Rick W Ransom, et al.
Journal of Medicinal Chemistry|December 1, 1985
A uniquely potent renin inhibitor and its unanticipated plasma binding componentB E Evans, K E Rittle, M G Bock, et al.
Journal of Medicinal Chemistry|October 24, 2023
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory DisordersDavid Harrison, Andy Billinton, Mark G Bock, et al.
Journal of Medicinal Chemistry|October 1, 1987
Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy terminiM G Bock, R M DiPardo, B E Evans, et al.
Journal of Medicinal Chemistry|March 4, 1994
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm laborP D Williams, P S Anderson, R G Ball, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Progress in the development of oxytocin antagonists for use in preterm laborD J Pettibone, M Guidotti, C M Harrell, et al.
Journal of Medicinal Chemistry|October 1, 1988
Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potencyM G Bock, R M DiPardo, B E Evans, et al.
Pageof 21